Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS · Delayed Price · Currency is USD
0.0390
0.00 (0.00%)
At close: May 22, 2026
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $99.18 thousand as of May 27, 2026. Its market cap has decreased by -99.22% in one year.
Market Cap
99.18K
Enterprise Value
2.83M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since October 20, 2020, Sigyn Therapeutics's market cap has decreased from 66.98M to 99.18K, a decrease of -99.85%. That is a compound annual growth rate of -68.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 99.18K | -96.39% |
| Dec 16, 2025 | 2.75M | -45.72% |
| Dec 17, 2024 | 5.06M | -16.78% |
| Dec 27, 2023 | 6.08M | -4.15% |
| Dec 29, 2022 | 6.34M | -66.00% |
| Dec 30, 2021 | 18.65M | -57.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovation Pharmaceuticals | 158.63K |
| Regen BioPharma | 153.59K |
| EV Biologics | 153.38K |
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| PaxMedica | 88.39K |
| Aridis Pharmaceuticals | 87.98K |
| Itoco | 85.64K |